Multicancer early detection tests are among the priorities of the Biden administration’s Cancer Moonshot. The tests show promise, but questions remain about when and how to use them.
Academic rigor, journalistic flair
Articles on Blood test
Displaying 1 - 20 of 21 articles
Your blood can hold a record of past illnesses. That information can reveal how many people have had a certain infection – like 58% of Americans having had COVID-19 by the end of February 2022.
Blood samples help doctors know whether a treatment is effective or not – and this device can provide this information almost instantly.
Proposals in NSW to force someone who spits at or bites a frontline worker to be tested for HIV and other blood-borne viruses are a real problem - for workers and the public.
We show that minute amounts of cancer DNA can be detected in blood more sensitively than ever before.
Expanding coronavirus testing is one of the most important tasks public health officials are tackling right now. But questions over accuracy of the two main types of tests have rightly caused concern.
The science is far from certain, but it appears at least a proportion of people who have had COVID-19 will be protected from another infection – at least initially.
After your body fights off an infection, antibodies remain in your blood. Two researchers explain how tests identify these antibodies and what the data can be used for.
We have no reliable way of knowing which patients’ cancer will return after surgery, so often chemotherapy is given to mop up any remaining cancer cells that may have gone undetected.
Researchers have discovered some blood markers that indicate melanoma. Here’s what has to happen for the test to reach clinics.
Feeling tired and out of energy? Talk to your GP about checking your iron level.
By measuring a cancer cell’s DNA in the bloodstream, scientists can get a snapshot of the cancer itself, which is referred as a “liquid biopsy”.
Labor’s shadow health minister Catherine King, said that the government has “cut bulk-billing payments for pathology and diagnostic imaging to make patients pay more”. Is that right?
Pathology Australia promptly abandoned its Don’t Kill Bulk Bill campaign against cuts to bulk-billing incentives after doing a deal with the federal government.
Industry consolidation and technological advances have completely reshaped the pathology industry over recent decades. But the way governments pay for pathology services hasn’t kept up.
Parents in three Australian states are being given misleading advice about the dangers of lead to babies and small children – including failing to warn pregnant women about miscarriage risks.
Complex algorithms and personalised medicine promise a new way of diagnosing disease.
Not so long ago, getting an x-ray for acute back pain was the norm. And they are still used far more frequently than is necessary.
A new blood test can predict whether women showing signs of early labour will go on to give birth too soon, according to…
A new study has suggested that it may be possible to develop blood tests for suicide by identifying biomarkers in the blood. Although it has its limitations, the study is an important step towards a more…
Top contributors
-
Associate Professor, School of Law, University of Canberra
-
Professor of Public Health, Bond University
-
Laureate Professor in Nutrition and Dietetics AO, University of Newcastle
-
Stephen Duckett is a Friend of The Conversation.
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice, The University of Melbourne
-
Associate Professor, Investigator for UNSW Digital Grid Futures Institute; Affiliated Investigator NHMRC Centre for Air Pollution, Energy and Health Research, Associate Investigator the ARC Centre of Excellence for Climate Extremes, UNSW Sydney
-
Professor of Clinical Epidemiology, Bond University
-
Clinical Lecturer, University of Cambridge
-
Professor, Public Service Research, UNSW Sydney
-
Associate Professor of Medicine, Infectious Diseases Physician, Australian National University
-
Professor of Bioinformatics, Nottingham Trent University
-
Associate Professor of Public Health, William Paterson University
-
Post Doctoral Research Fellow in Melanoma, Edith Cowan University
-
Professor, Edith Cowan University
-
Associate Professor, Walter and Eliza Hall Institute
-
Professor of Neuroimaging & Psychopharmacology, King's College London
